The verification system searches a global clinical database registry to identify participants that are currently enrolled in other clinical studies, improving participant selection and higher data integrity.
Using this tool, Celerion will effectively screen and select higher quality participants to identify ineligible candidates for enrollment.
Verified Clinical Trials CEO Mitchell Efros said the system will streamline the clinical trial process and offers protection from various other potential liabilities.
"Verified Clinical Trials offers a comprehensive and unique clinical research database registry to enhance the quality of both early and late stage studies globally," Efros added.